Clinical trial
A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the…
NCT00001438 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001438 |
|---|---|
| Title | A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes |
| Official title | A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders |
| Intervention type | Drug |
| Interventions | all-trans-retinoic acid with IFN-alpha2a |
| Enrollment | 30 |
| Start date | Jun 1, 1995 |
| Completion | Dec 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: